News
Scientists have developed a 3D-printed implant that delivers targeted electrical stimulation to damaged areas of the spinal ...
Scientists have successfully grown over 400 different types of nerve cells from stem cells in the lab—a groundbreaking step toward replicating the complexity of the human brain.
Hippocampal single-cell RNA Atlas of chronic methamphetamine abuse-induced cognitive decline in mice
The authors proposed two hypotheses: first, that methamphetamine induces neuroinflammation, and second, that it alters neuronal stem cell differentiation. These are valuable hypotheses, and the ...
Once dismissed as “junk,” a group of RNA molecules has been found to help regrow damaged nerves in mice in new research. The ...
Scientists at ETH Zurich have broken new ground by generating over 400 types of nerve cells from stem cells in the lab, far surpassing previous efforts that produced only a few dozen. By ...
Stem cell tech simulates ALS, quantum tools decode quasicrystals, and cancer exploits a human mutation—three breakthroughs ...
By shutting down a hyperactive enzyme, scientists got damaged brain cells to regrow their lost “antennae” and restart dopamine signaling—hinting at a possible way to reverse Parkinson’s effects.
Stanford researchers discovered that dialing down an overactive enzyme, LRRK2, can regrow lost cellular “antennae” in key brain cells, restoring vital dopamine communication and neuroprotective ...
We are proud to announce the official launch of Brain Defender, our groundbreaking cognitive support formula designed to enhance mental clarity, focus, memory, and long-term brain health. Developed ...
Putting the brakes on an enzyme might rescue neurons that are dying due to a type of Parkinson's disease that's caused by a single genetic mutation, according to a new Stanford Medicine-led study ...
A previously unknown structure discovered in our cells could pave the way toward new treatments for various genetic disorders. The existence of the organelle—which has been dubbed the ...
Chronic pain affects millions of people in the US. Targeting an oft-overlooked brain receptor could one day offer relief.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results